Intramyocardial bone marrow mononuclear cells ( BMMNC ) implantation concomitant to coronary artery bypass grafting ( CABG ) surgery as an option for regenerative therapy in chronic ischemic heart failure was tested in a very few number of studies , with not consistent conclusions regarding improvement in left ventricular function , and with a follow-up period between 6 months and 1 year .